{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:21:47Z","timestamp":1785450107554,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003810","name":"Hospital de Cl\u00ednicas de Porto Alegre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Electrocardiology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jelectrocard.2021.10.002","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T06:40:21Z","timestamp":1633761621000},"page":"19-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Growth\/differentiation factor-15 (GDF-15) as a predictor of serious arrhythmic events in patients with nonischemic dilated cardiomyopathy"],"prefix":"10.1016","volume":"70","author":[{"given":"Bruna Miers","family":"May","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano Nunes","family":"Kochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Arbo","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Scolari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Zimerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Andrades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro I.","family":"Zimerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jelectrocard.2021.10.002_bb0005","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.jelectrocard.2021.10.002_bb0010","first-page":"1601","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"issue":"27","key":"10.1016\/j.jelectrocard.2021.10.002_bb0015","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.jelectrocard.2021.10.002_bb0020","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT)","volume":"105","author":"B\u00e4nsch","year":"2002","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.jelectrocard.2021.10.002_bb0025","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jelectrocard.2021.10.002_bb0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.jelectrocard.2021.10.002_bb0035","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jelectrocard.2021.10.002_bb0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jacc.2020.05.061","article-title":"Long-term outcomes of implantable cardioverter-defibrillator therapy in the SCD-HeFT","volume":"76","author":"Poole","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jelectrocard.2021.10.002_bb0045","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/eurheartj\/ehz788","article-title":"The role of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome","volume":"41","author":"Goldenberg","year":"2020","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.jelectrocard.2021.10.002_bb0050","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/europace\/eut228","article-title":"The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy","volume":"15","author":"Disertori","year":"2013","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.jelectrocard.2021.10.002_bb0055","first-page":"348","article-title":"Stratification of the risk of sudden death in nonischemic heart failure","volume":"103","author":"Pimentel","year":"2014","journal-title":"Arq Bras Cardiol"},{"issue":"5","key":"10.1016\/j.jelectrocard.2021.10.002_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015139","article-title":"Time to shock the system: moving beyond the current paradigm for primary prevention implantable cardioverter-defibrillator use","volume":"9","author":"Merchant","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.jelectrocard.2021.10.002_bb0065","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jelectrocard.2021.10.002_bb0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","article-title":"Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"7","author":"Kuruvilla","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jelectrocard.2021.10.002_bb0075","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3389\/fphys.2018.01712","article-title":"GDF15 and growth control","volume":"9","author":"Emmerson","year":"2018","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.jelectrocard.2021.10.002_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232280","article-title":"Characterizing heart failure with preserved and reduced ejection fraction: an imaging and plasma biomarker approach","volume":"15","author":"Kanagala","year":"2020","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jelectrocard.2021.10.002_bb0085","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/eurjhf\/hfs120","article-title":"Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support","volume":"14","author":"Lok","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.jelectrocard.2021.10.002_bb0090","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1111\/jcmm.13540","article-title":"GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2","volume":"22","author":"Stojkovic","year":"2018","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.jelectrocard.2021.10.002_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10840-016-0213-7","article-title":"Predictors of serious arrhythmic events in patients with nonischemic heart failure","volume":"48","author":"Pimentel","year":"2017","journal-title":"J Interv Card Electrophysiol"},{"issue":"22","key":"10.1016\/j.jelectrocard.2021.10.002_bb0100","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/eurheartj\/ehp300","article-title":"Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy","volume":"30","author":"Foley","year":"2009","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.jelectrocard.2021.10.002_bb0105","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00392-019-01554-3","article-title":"Circulatory factors associated with function and prognosis in patients with severe heart failure","volume":"109","author":"Rullman","year":"2020","journal-title":"Clin Res Cardiol"},{"issue":"10","key":"10.1016\/j.jelectrocard.2021.10.002_bb0110","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/europace\/eur147","article-title":"Defining potential to benefit from implantable cardioverter defibrillator therapy: the role of biomarkers","volume":"13","author":"Scott","year":"2011","journal-title":"Europace."},{"key":"10.1016\/j.jelectrocard.2021.10.002_bb0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ahj.2019.10.020","article-title":"Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure \u2014 DANISH-MRI","volume":"221","author":"Elming","year":"2020","journal-title":"Am Heart J"},{"issue":"14","key":"10.1016\/j.jelectrocard.2021.10.002_bb0120","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.109.928846","article-title":"Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the valsartan heart failure trial","volume":"122","author":"Anand","year":"2010","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jelectrocard.2021.10.002_bb0125","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jchf.2017.07.013","article-title":"Utility of growth differentiation factor-15, a marker of oxidative stress and inflammation, in chronic heart failure: insights from the HF-ACTION study","volume":"5","author":"Sharma","year":"2017","journal-title":"JACC Hear Fail"},{"issue":"12","key":"10.1016\/j.jelectrocard.2021.10.002_bb0130","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/ejhf.1301","article-title":"Growthdifferentiation factor-15 is not modified by sacubitril\/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial","volume":"20","author":"Bouabdallaoui","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jelectrocard.2021.10.002_bb0135","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.12659\/MSM.910671","article-title":"Additional diagnostic value of growth differentiation factor-15 (GDF-15) to N-terminal B-type natriuretic peptide (NT-proBNP) in patients with different stages of heart failure","volume":"24","author":"Li","year":"2018","journal-title":"Med Sci Monit"}],"container-title":["Journal of Electrocardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073621002090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073621002090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T12:32:21Z","timestamp":1758285141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022073621002090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":27,"alternative-id":["S0022073621002090"],"URL":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2021.10.002","relation":{},"ISSN":["0022-0736"],"issn-type":[{"value":"0022-0736","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth\/differentiation factor-15 (GDF-15) as a predictor of serious arrhythmic events in patients with nonischemic dilated cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Electrocardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2021.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}